Memorial Sloan Kettering doctors talk about moving cancer clinical trials research forward through collaborations with community hospitals.
Hear from our experts on how the MSK Cancer Alliance has the potential to improve patient outcomes by bringing the latest cancer advances directly into local communities.
The Memorial Sloan Kettering Cancer Alliance is an initiative designed to collaboratively guide community providers toward state-of-the-art cancer care. Our overarching goal is to improve the lives of cancer patients through dynamic partnerships with local care providers.
The concept of the alliance emerged out of a growing awareness that community oncologists deliver the vast majority of cancer care in the United States, but advances in treatment and research can take years to reach those patients. We believe that a collaborative partnership such as the Memorial Sloan Kettering Cancer Alliance can not only help meet a rising need for access to high-quality cancer care and clinical trials, but improve patient outcomes while also giving us an opportunity to understand from our partners how care is best delivered in the community setting.
Central to the Memorial Sloan Kettering Cancer Alliance is a mutual willingness to learn from one another and a shared vision of our partnership as an ongoing endeavor tailored to meet the unique needs of our members and the communities they serve. The design of each alliance partnership can vary depending on specific member needs. Components might include the adoption of Memorial Sloan Kettering standards of care as well as access to our robust portfolio of clinical trials.
Read more about the MSK Cancer Alliance members.